Brainard Diana — SEC Form 4 filings
SEC reporting owner CIK 1818070. 18 Form 4 filings on record with FilingPulse; latest filed 2025-10-01.
Transaction summary — filings shown
Covers all 18 filings on record, filed 2024-01-25 to 2025-10-01. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 18 legs across 17 filings — 149,879 shares, $108,298 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 1.
- Largest priced transaction: sale of 41,421 shares @ $0.67 ($27,752) in Allovir, Inc., filed 2024-02-06.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Allovir, Inc. (ALVR) | Chief Executive Officer, Director | 17 | — | 18 legs · 149,879 sh · $108,298 | — |
| NEKTAR THERAPEUTICS (NKTR) | Director | 1 | — | — | 1 |
Form 4 filings — Brainard Diana
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2025-10-01 | 4 | NEKTAR THERAPEUTICS (NKTR) | Grant/award (A): 8,000 (derivative) @ $0 | EDGAR |
| 2024-11-20 | 4 | Allovir, Inc. (ALVR) | Sale (S): 8,706 @ $0.55 | EDGAR |
| 2024-11-06 | 4 | Allovir, Inc. (ALVR) | Sale (S): 10,609 @ $0.86 | EDGAR |
| 2024-10-23 | 4 | Allovir, Inc. (ALVR) | Sale (S): 9,752 @ $0.78 | EDGAR |
| 2024-10-04 | 4 | Allovir, Inc. (ALVR) | Sale (S): 1,493 @ $0.81 | EDGAR |
| 2024-08-22 | 4 | Allovir, Inc. (ALVR) | Sale (S): 5,390 @ $0.74 | EDGAR |
| 2024-08-20 | 4 | Allovir, Inc. (ALVR) | Sale (S): 3,091 @ $0.76 | EDGAR |
| 2024-08-07 | 4 | Allovir, Inc. (ALVR) | Sale (S): 10,847 @ $0.73 | EDGAR |
| 2024-07-23 | 4 | Allovir, Inc. (ALVR) | Sale (S): 9,731 @ $0.75 | EDGAR |
| 2024-07-03 | 4 | Allovir, Inc. (ALVR) | Sale (S): 1,489 @ $0.72 | EDGAR |
| 2024-05-23 | 4 | Allovir, Inc. (ALVR) | Sale (S): 5,149 @ $0.79 | EDGAR |
| 2024-05-21 | 4 | Allovir, Inc. (ALVR) | Sale (S): 3,075 @ $0.75 | EDGAR |
| 2024-05-07 | 4 | Allovir, Inc. (ALVR) | Sale (S): 10,240 @ $0.80 | EDGAR |
| 2024-04-23 | 4 | Allovir, Inc. (ALVR) | Sale (S): 9,601 @ $0.75 | EDGAR |
| 2024-04-04 | 4 | Allovir, Inc. (ALVR) | Sale (S): 1,533 @ $0.77 | EDGAR |
| 2024-02-22 | 4 | Allovir, Inc. (ALVR) | Sale (S): 3,097 @ $0.70 · Sale (S): 5,155 @ $0.71 | EDGAR |
| 2024-02-06 | 4 | Allovir, Inc. (ALVR) | Sale (S): 41,421 @ $0.67 | EDGAR |
| 2024-01-25 | 4 | Allovir, Inc. (ALVR) | Sale (S): 9,500 @ $0.67 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1818070 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →